| DB ID | MyCo_1166 |
| Title | (1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia |
| Year | 1996 |
| PMID | 8991635 |
| Fungal Diseases involved | Pneumocystis carinii pneumonia |
| Associated Medical Condition | HIV-AIDS |
| Genus | Pneumocystis |
| Species | carinii |
| Organism | Pneumocystis carinii |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | Human sera were obtained from seven consecutive patients with AIDS and PCP. |
| Cohort No. | 7 |
| Age Group | None |
| P Value | p<0.05 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | BDG detection kit (G test; Seikagaku Corporation) |
| ELISA kits | BDG detection kit (G test; Seikagaku Corporation) |
| Assay Data | None |
| Validation Techniques used | BDG G test |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
